E. Scott Priestley - Concepedia

Author

E. Scott Priestley

Bristol-Myers Squibb (United States)ORCID

Also Known As

E Priestley, E Scott Priestley, E. S. Priestley, E. S. PRIESTLEY, E. Scott Priestley, E.Scott Priestley, Emilie Priestley, Pancras Wong, Priestley, E. Scott

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Scripps Research Institute Biocon (India)Université de Montréal Institute for Research in Immunology and Cancer

About

E. Scott Priestley is an author at Bristol-Myers Squibb (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	853
2	Natural Sciences	11	11	721
3	Biochemistry	11	11	706
4	Engineering	2	2	57
5	Biomolecular Engineering	2	2	57

E. Scott Priestley

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Design and Synthesis of New Aminoglycoside Antibiotics Containing Neamine as an Optimal Core Structure: Correlation of Antibiotic Activity with in Vitro Inhibition of Translation William A. Greenberg, E. Scott Priestley, P.S. Sears, Journal of the American Chemical Society Peptide ScienceAntimicrobial ChemotherapyChemical BiologyA-site RnaPharmaceutical Chemistry	1999	216
Direct Observation of Aminoglycoside−RNA Interactions by Surface Plasmon Resonance Martin Hendrix, E. Scott Priestley, Gerald F. Joyce, Journal of the American Chemical Society	1997	204
Specificity of aminoglycoside antibiotics for the A-site of the decoding region of ribosomal RNA Chi‐Huey Wong, Martin Hendrix, E. Scott Priestley, Chemistry & Biology BiochemistryRibosomal RnaNatural SciencesRna Structure PredictionMolecular Biology	1998	154
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding Pancras C. Wong, Dietmar Seiffert, J. Eileen Bird, Science Translational Medicine ImmunologyPharmacotherapyPlatelet AggregationInflammationThrombosis	2017	144
Hydroxyamines as a New Motif for the Molecular Recognition of Phosphodiesters: Implications for Aminogloycoside–RNA Interactions Martin Hendrix, Phil B. Alper, E. Scott Priestley, Angewandte Chemie International Edition in English Chemical BiologyNucleic Acid ChemistryBiochemistryNatural SciencesRna Structure Prediction	1997	88
P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease E. Scott Priestley, Indawati De Lucca, Bahman Ghavimi, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicineAntiviral Drug Development	2002	62
Atropisomer Control in Macrocyclic Factor VIIa Inhibitors Peter W. Glunz, Luciano Mueller, Daniel L. Cheney, Journal of Medicinal Chemistry Combinatorial ChemistryBioorganic ChemistryMolecular BiologyPharmacotherapyChemical Biology	2016	52
Design of an N7-Glycosylated Purine Nucleoside for Recognition of GC Base Pairs by Triple Helix Formation Juerg Hunziker, E. Scott Priestley, Helmut Brunar, Journal of the American Chemical Society	1995	46
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial Chris Parker, Noel W. Clarke, Adrian Cook, The Lancet	2024	43
Methylenecyclopropanecarboxylates and -dicarboxylates, efficient reagents for the [3 + 2] methylenecyclopentane annulation of unactivated and electron-rich alkenes Daniel A. Singleton, Chad C. Huval, Kevin M. Church, Tetrahedron Letters EngineeringAlkene MetathesisElectron-rich AlkenesOrganic ChemistryOrganometallic Catalysis	1991	42

Page 1